In the Chanin case, Teva argues, Propofol contained several specific warnings, both on the package containing vials of the anesthetic and on the vials themselves, against using the drug on multiple patients.
FORBES: Teva Appeals $500 Million Verdict Over Nightmarish Clinic Practices